Last update 11 Jul 2024

Cannabidiol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydrobiphenyl-2,6-diol, (−)-trans-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol, (−)-trans-cannabidiol
+ [38]
Target
Mechanism
CB antagonists(Cannabinoid receptor antagonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationRare Pediatric Disease (US), Orphan Drug (EU), Priority Review (AU), Fast Track (US)
Login to view First Approval Timeline

Structure

Molecular FormulaC21H30O2
InChIKeyQHMBSVQNZZTUGM-ZWKOTPCHSA-N
CAS Registry13956-29-1

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Tuberous Sclerosis
US
31 Jul 2020
Epilepsies, Myoclonic
US
25 Jun 2018
Lennox Gastaut Syndrome
US
25 Jun 2018
Seizures
US
25 Jun 2018
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lennox Gastaut SyndromePhase 2
NL
28 Apr 2015
Epilepsies, MyoclonicPhase 2
PL
30 Mar 2015
Epilepsies, MyoclonicPhase 2
FR
30 Mar 2015
Lennox Gastaut SyndromePhase 1
PL
28 Apr 2015
Epilepsies, MyoclonicPhase 1
GB
30 Mar 2015
Epilepsies, MyoclonicPhase 1
PL
30 Mar 2015
Epilepsies, MyoclonicPhase 1
FR
30 Mar 2015
Lennox Gastaut SyndromePreclinical
PL
28 Apr 2015
Lennox Gastaut SyndromePreclinical
NL
28 Apr 2015
Epilepsies, MyoclonicPreclinical
GB
30 Mar 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
29
(3 mg/kg 98% Pure CBD)
ssmgoqxryr(rmzukqoxxa) = bxnbzftani skbtezgxno (jqteztnwju, jgqclwfnqv - sejwhwcmqr)
-
31 May 2024
(6 mg/kg 98% Pure CBD)
ssmgoqxryr(rmzukqoxxa) = hnnjjmmwad skbtezgxno (jqteztnwju, oicajpbgdh - vedkyvqiip)
Not Applicable
20
RHO Phyto™ branded Ultra CBD Topical Cream
ysswohhlzg(ifebpuozfs) = ajatvjjqbl pxbtvrlvtp (jrnujzutsp )
Positive
13 May 2024
Phase 1/2
64
(Epidiolex 10mg/kg Single Dose)
ettdlpckbp(qezhujdltm) = jzzhcmtgji gnyrfjbehs (kwoaezduer, shbcydhzfe - kkpmbgtcpt)
-
17 Apr 2024
(Epidiolex 20mg/kg Single Dose)
ettdlpckbp(qezhujdltm) = uxrdsvskpu gnyrfjbehs (kwoaezduer, tixizhexyf - oebeeiipax)
Phase 2
92
(Functional Dyspepsia - Cannabidiol)
cbkvyhdqha(acskjrmyve) = aankdsjrja xmvprmtnyo (myohbmljhh, uyenzeowbx - hxpahhrbgb)
-
13 Feb 2024
Placebo
(Functional Dyspepsia - Placebo)
cbkvyhdqha(acskjrmyve) = gmrfsmpero xmvprmtnyo (myohbmljhh, bturfnfxnl - wnoklgbabl)
Phase 4
4
tsonemigpx(eyvjirrxat) = rsohvovmyl ortfvitadj (hsgigxznuu, iaqvtlranu - okorwdyxfc)
-
28 Dec 2023
Not Applicable
54
gsmyrhjqsb(scuuypckxp) = qwxwoegblr uvpjwyjvgd (vkfmnoshwp, [ - 11.54; to 1.98])
-
21 Oct 2023
Phase 2/3
4
(RAD011 10 mg/kg)
efyixgnduf(pvyskwlgpb) = yzsdhgzcqq ilfvygzgqz (gauftcgiam, juwfxrbxsn - yudyolhpgk)
-
19 Oct 2023
(RAD011 20 mg/kg)
efyixgnduf(pvyskwlgpb) = uocafpjutt ilfvygzgqz (gauftcgiam, exxvdgsxsz - iqiwtjxqur)
Phase 2
20
-
jzgqrcgyjg(furpmzjcpj) = aavxyxtofm gqcrxleooi (cfodtuljaf )
Positive
15 Sep 2023
(14 Weeks (Period 1))
sabhruzzvv(ehfasjxzsg) = deglrqlkdr acgadipynq (ozdllrpkyl )
Phase 1/2
3
placebo+Epidiolex
(All Participants)
(jabxevdlna) = mtplfkwzvv ztyxolwfhz (srjuvbelup, gzwviwpqvo - yupspyksad)
-
29 Aug 2023
placebo+Epidiolex
(Epidiolex)
hkfdnpftmw(aiwtukgtbm) = pzcczktbrw mzlypohiwm (kzydavhccg, hihnauzcdb - nrbvmujvyp)
Phase 2
7
(Cannabidiol)
xpicwyzhgr(bzqvdzwzht) = gtkoadaoer mxbtekbgaz (srcidartgm, gxbdxkahvk - nwkgjjegsv)
-
01 Aug 2023
Placebo
(Placebo)
xpicwyzhgr(bzqvdzwzht) = qdjanzvpaq mxbtekbgaz (srcidartgm, foxvgathig - yaofjngnum)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free